Expanded Access Programs 2015 is a conference dedicated to US and global models for stakeholder collaboration, program design, supply equity and access to investigational drugs.
Expanded Access Programs 2015 covers topics such as:
- The new FDA guidance and early access form
- The Andrea Sloan CURE Act and Right to Try Laws
- Global protocol development and analyze country-specific regulations
- New models for simplified and accelerated access to investigational medicine
- The pricing, payment and reimbursement policy for EAPs
- Physician collaboration models for advancing access to lifesaving therapies
- Innovative outreach and educational efforts to align stakeholders
- Strategies for ethical, compliant and successful managed access programs
- Strategies for forecasting and establishing supply
- Social media for advocacy, access and awareness
Expanded Access Programs 2015 brings together attendees with responsibilities in:
- Regulatory Affairs
- Medical Affairs
- Clinical Affairs
- Patient Advocacy
- Managed Markets
- Rare Disease Products
- Pharmacovigilance
- Market Access
- Legal
- Safety
